Medzip Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.15 M
as on 05-12-2024
- Paid Up Capital ₹ 0.15 M
as on 05-12-2024
- Company Age 11 Year, 30 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.50 M
as on 05-12-2024
- Revenue -12.79%
(FY 2022)
- Profit 15.84%
(FY 2022)
- Ebitda -1.98%
(FY 2022)
- Net Worth -15.77%
(FY 2022)
- Total Assets -14.58%
(FY 2022)
About Medzip Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.15 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹0.50 M.
Anand Kulkarni, Purnapradna Kulkarni, Santosh Bommannavar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24301KA2013PTC072177
- Company No.
072177
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medzip Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Kulkarni  | Director | 28-Nov-2013 | Current |
| Purnapradna Kulkarni | Director | 28-Nov-2013 | Current |
| Santosh Bommannavar | Director | 28-Nov-2013 | Current |
| Kalpana Pacheri | Director | 21-Jan-2014 | Current |
Financial Performance of Medzip Pharmaceuticals.
Medzip Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 12.79% decrease. The company also saw a substantial improvement in profitability, with a 15.84% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medzip Pharmaceuticals?
In 2022, Medzip Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Mar 2016 | ₹0.50 M | Open |
How Many Employees Work at Medzip Pharmaceuticals?
Unlock and access historical data on people associated with Medzip Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medzip Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medzip Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
